ISLAMABAD/LONDON: The UK government on Friday announced its latest travel review in which they removed Pakistan from its red travel list but passengers travelling from Pakistan to the UK are subjected to new rules.
According to the Geo News report, conditions related to the approved COVID-19 vaccines remain in place and will continue to be applied strictly.
Fully vaccinated Pakistanis with one of the European Medicines Agency (EMA) authorised vaccines which are Pfizer, Moderna, Oxford AstraZeneca or Janssen (Johnson & Johnson) are permitted to enter the UK and exempted from quarantine and testing under the rules.
Sinopharm and Sinovac are approved by the World Health Organisation (WHO) but these are not approved by the UK government and are not part of the UK approved list of five vaccines.
The British government says it will also recognise travellers as fully vaccinated if they were jabbed in another 17 countries, including Australia, New Zealand, Japan, Israel and Canada.
Mandatory hotel quarantine at the cost of £2,285 per person will not apply anymore from 22 September onwards but those travelling without the UK approved and above-mentioned four vaccines will need to self-isolate at a designated place, either home, hotel or hostel.
Meanwhile, there are some simpler and cheaper rules for fully vaccinated travellers coming from non-red list countries such as Pakistan that will apply to fully vaccinated passengers.
Day 2 PCR tests will be replaced with cheaper lateral flow tests – from the end of October – and passengers will no longer need to take pre-departure tests (PDTs).
From Monday 4 October 4 am, eligible fully vaccinated travellers will no longer need to take a PDT when travelling to England. The PCR or lateral flow test must be taken three days before returning to the UK from Pakistan.
Tests after arrival in the UK must be PCR tests and must be booked before travel.
On the other hand, Passengers testing positive will need to isolate and take a PCR test, at no additional cost to the traveller, which would be genomically sequenced to help identify new variants.